Patents
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
08/2014
08/26/2014CA2691539C Modified toxins
08/26/2014CA2582252C Therapeutic use of anti-tf-antigen antibody
08/26/2014CA2523620C Drug releasing biodegradable fiber for delivery of therapeutics
08/26/2014CA2512867C Vitamin receptor binding drug delivery conjugates
08/21/2014WO2014127370A1 Method and composition for dispersions of gold nanoparticles
08/21/2014WO2014127365A1 Psma ligands and uses thereof
08/21/2014WO2014127357A1 Supramolecular magnetic nanoparticles
08/21/2014WO2014127118A1 Anise flavored medication
08/21/2014WO2014127116A1 Topical ocular analgesic agents
08/21/2014WO2014126836A1 Tubulysin compounds, methods of making and use
08/21/2014WO2014126537A1 A Polymeric System for Release of an Active Agent
08/21/2014WO2014126536A1 Photo-responsive macro- and micro- liquid marbles
08/21/2014WO2014125340A1 Smoke liquid for atomizers and/or vaporizers
08/21/2014WO2014125256A1 Nanoparticle delivery compositions
08/21/2014WO2014102755A4 Bortezomib formulations
08/21/2014WO2014102312A3 Minimally toxic prodrugs
08/21/2014US20140236080 Pary-xylene based microfilm elution devices
08/21/2014US20140236071 Light-enabled drug delivery
08/21/2014US20140235835 Calicheamicin derivative-carrier conjugates
08/21/2014US20140235799 Method for preparation of a controlled release system
08/21/2014US20140235790 Carbohydrate-based compositions and methods for targeted drug delivery
08/21/2014US20140235729 Benzylamine containing compositions and methods for appetite suppression
08/21/2014US20140235721 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid
08/21/2014US20140235715 Taste masking formulations of fatty acids
08/21/2014US20140235708 Pharmaceutical composition on the basis of nanomicelles containing epigallocatechin gallate and a method of administration thereof to treat atopic dermatitis, crohn's disease, adenomyosis, and hyperplastic diseases of the prostate gland
08/21/2014US20140235706 Cancer cell targeting using nanoparticles
08/21/2014US20140235698 RNA Aptamer Specifically Binding to Carcinoembryonic Antigen and Use thereof
08/21/2014US20140235664 Stable pharmaceutical formulations of methylnaltrexone
08/21/2014US20140235648 Liquid preparation comprising pimobendan
08/21/2014US20140235574 Aripiprazole complex formulation and method
08/21/2014US20140235557 Small Efficient Cell Penetrating Peptides Derived From The Scorpion Toxin Maurocalcine
08/21/2014US20140235555 Pharmaceutical compositions comprising polyethylene glycol having a molecular weight of less than 600 daltons
08/21/2014US20140235554 Ophthalmic formulation derived from silk protein
08/21/2014US20140235550 Antineoplastic Hydrogels, and Enzyme-Instructed Preparations Thereof
08/21/2014US20140235536 Injectable solution at ph 7 comprising at least one basal insulin the isoelectric point of which is comprised in 5.8 and 8.5 and an anionic compound bearing carboxylate charges and hydrophobic radicals
08/21/2014US20140235532 Immunogenic escherichia coli heat stable enterotoxin
08/21/2014US20140234961 SYNTHETIC SINGLE CHAIN VARIABLE DOMAIN (SCFV) IMMUNOGLOBULIN FRAGMENT VEHICLE CONTAINING FUSION PROTEINS FOR TARGETED INTRODUCTION OF siRNA
08/21/2014US20140234945 Transthyretin variants
08/21/2014US20140234903 Biosynthetic gene cluster for the production of peptide/protein analogues
08/21/2014US20140234448 Disinfecting Formulations and Uses Thereof
08/21/2014US20140234444 Method of using a film-shaped preparation comprising oily substances for oral administration
08/21/2014US20140234428 Topical dermal delivery compositions using self assembling nanoparticles with cetylated components
08/21/2014US20140234427 Use of synthetic janus particles for preventing or reducing crystal growth
08/21/2014US20140234420 Method of Treating Skin Disorders using Nanoscale Delivery Devices and Transdermal Enhancing Compositions
08/21/2014US20140234413 Caged platinum nanoclusters for anticancer chemotherapeutics
08/21/2014US20140234403 Liposome production using isopropanol
08/21/2014US20140234400 Targeted Lipid-Drug Formulations for Delivery of Drugs to Myeloid and Lymphoid Immune Cells
08/21/2014US20140234396 External patches containing etofenamate
08/21/2014US20140234375 Compositions and Methods for Eliciting an Immune Response to Escape Mutants of Targeted Therapies
08/21/2014US20140234373 Methods of Promoting Immune Tolerance
08/21/2014US20140234365 2-hydroxyhippuric acid analogs, and methods for their synthesis and use
08/21/2014US20140234362 Defensin-antigen fusion proteins
08/21/2014US20140234360 Influenza vaccine
08/21/2014US20140234356 Influenza antigen delivery vectors and constructs
08/21/2014US20140234352 B7-h3 and b7-h4, novel immunoregulatory molecules
08/21/2014US20140234348 Universal Immune Receptor Expressed by T Cells for the Targeting of Diverse and Multiple Antigens
08/21/2014US20140234346 Pyrrolobenzodiazepines
08/21/2014US20140234345 Novel anti-cancer isocarbostyril alkaloid conjugates
08/21/2014US20140234318 Tumor specific oligosaccharide epitopes and use thereof
08/21/2014US20140234311 Albumin variants
08/21/2014US20140234308 Treatment of breast cancer with companion diagnostic
08/21/2014US20140234297 Antibody constant domain regions and uses thereof
08/21/2014US20140234255 Microdystrophin peptides and methods for treating muscular dystrophy using the same
08/21/2014US20140234225 Method of treatment using nanoparticulate compositions having lysozyme as a surface stabilizer
08/21/2014US20140234220 Method and composition for dispersions of gold nanoparticles
08/21/2014US20140234217 Remote assembly of targeted nanoparticles using complementary oligonucleotide linkers
08/21/2014US20140234214 Methods of Treating a Tauopathy
08/21/2014US20140234212 Targeted Buccal Delivery of Agents
08/21/2014US20140234211 Supramolecular aggregates containing amphiphilic monomers, chelating agents and peptides for use for drug delivery and as contrast agents
08/21/2014US20140231710 Method of making a formulation for deactivating nucleic acids
08/21/2014US20140230833 Nicotine delivery product and method for producing it
08/21/2014DE50103551C5 Neue tiotropium-haltige inhalationspulver New tiotropium-containing inhalation powder
08/21/2014DE112012003995T5 Caspofunginpräparat mit geringem Verunreinigungsgehalt, Verfahren zu seiner Herstellung und seine Verwendung Caspofunginpräparat with low impurity content, process for its preparation and its use
08/21/2014DE10066235C5 Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens Method and medicament for the inhibition of expression of a given gene
08/20/2014EP2767293A1 Composition for the accelerated wound healing of damaged tissue
08/20/2014EP2767292A1 Sustained Local Anesthetic Composition Containing SAIB
08/20/2014EP2767285A1 Tablet including 7-[4-(4-benzo[beta]thiophen-4-yl-piperazin-1-yl) butoxy]-1h-quinolin-2-one or salt thereof
08/20/2014EP2767274A1 Carotenoid-containing composition and method for producing same
08/20/2014EP2766094A2 Compositions for binding to amyloid proteins
08/20/2014EP2766051A1 Porphyrin-phospholipid conjugate microbubbles and their use as contrast agents.
08/20/2014EP2766048A1 Pyrrolobenzodiazepines and conjugates thereof
08/20/2014EP2766047A1 Methods
08/20/2014EP2766046A2 Metal-organic frameworks with exceptionally large pore aperatures
08/20/2014EP2765999A1 Ingestible multi-sheet unit having predetermined functions and combinations
08/20/2014EP2765997A2 Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery including transdermal delivery of cargo and methods thereof
08/20/2014EP2765992A1 Foam formulations
08/20/2014EP2765991A1 In situ forming hydrogel and method using same
08/20/2014EP2765990A2 Solid dispersion
08/20/2014EP2765987A1 Compositions for the treatment of dry eye
08/20/2014EP2765986A1 Prevention and treatment of ocular conditions
08/19/2014US8809504 Inhibitor which is deactivatable by a reagent produced by a target cell
08/19/2014US8809502 Mutated anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cells
08/19/2014US8809495 Peptides imparting cell permeability to lipid membrane structure and/or enhancing cell permeability of lipid membrane structure, and lipid membrane structure comprising lipid bound to such peptide as constituent lipid and having cell permeability or showing enhanced cell permeability
08/19/2014US8809453 Branched polymers
08/19/2014US8809452 Damage self-reporting polymer materials having at least two phases
08/19/2014US8809398 Liquid formulations containing a carotinoid
08/19/2014US8809320 Benzodiazepine derivatives
08/19/2014US8809286 Conjugated antimicrobial agents
08/19/2014US8809277 Dual secured therapeutic peptide delivery system
08/19/2014US8809261 Compositions containing delta-9-THC-amino acid esters and process of preparation
1 ... 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 ... 1712